GlyCardial Diagnostics’ technology is based on the quantification of specific protein modifications as a novel and disruptive approach to detect cardiac ischemia

GlyCardial Diagnostics’ technology is based on the quantification of specific protein modifications as a novel and disruptive approach to detect cardiac ischemia

The development of our novel assay would represent:

due to the current lack of early biomarkers for the detection of ischemia for the diagnosis and prognosis of ischemic events

as we will obtain a sensitive and reproducible method to allow the rapid quantification of the glycosylated forms of a specific glycoprotein